﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2014v5.0" xsi:schemaLocation="http://www.irs.gov/efile">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2015-06-01T16:21:06-07:00</ReturnTs>
    <TaxPeriodEndDt>2014-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>LaRue Corrigan McCormick &amp; Teasdale LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>5959 Topanga Canyon Blvd Suite 180</AddressLine1Txt>
        <CityNm>Woodland Hills</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91367</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2014-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>266461545</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>The Guthy-Jackson Charitable Foundation</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>GUTH</BusinessNameControlTxt>
      <PhoneNum>3104325400</PhoneNum>
      <USAddress>
        <AddressLine1Txt>1018 Pamela Drive</AddressLine1Txt>
        <CityNm>Beverly Hills</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>90210</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>William R Guthy</PersonNm>
      <PersonTitleTxt>CO TRUSTEE</PersonTitleTxt>
      <SignatureDt>2015-06-01</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>Mike McCormick</PreparerPersonNm>
      <PTIN>P00182870</PTIN>
      <PhoneNum>8185879300</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2014</TaxYr>
    <BuildTS>2016-02-25 16:41:14Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990PF documentId="IRS990PF" referenceDocumentId="GeneralExplanation" softwareId="14000265" softwareVersionNum="2014v5.0">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>29828</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>5126644</ContriRcvdRevAndExpnssAmt>
        <TotalRevAndExpnssAmt>5126644</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>0</TotalNetInvstIncmAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="LegalFeesSchedule">26907</LegalFeesRevAndExpnssAmt>
        <LegalFeesDsbrsChrtblAmt>26907</LegalFeesDsbrsChrtblAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="AccountingFeesSchedule">4950</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesChrtblPrpsAmt>4950</AccountingFeesChrtblPrpsAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="OtherProfessionalFeesSchedule">105300</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesDsbrsChrtblAmt>105300</OtherProfFeesDsbrsChrtblAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="TaxesSchedule">160</TaxesRevAndExpnssAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="OtherExpensesSchedule AmortizationSchedule">20377</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesDsbrsChrtblAmt>20377</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>157694</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>0</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>157534</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>4986847</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>4986847</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>5144541</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>0</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>5144381</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>-17897</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>47725</CashBOYAmt>
        <CashEOYAmt>29828</CashEOYAmt>
        <CashEOYFMVAmt>29828</CashEOYFMVAmt>
        <TotalAssetsBOYAmt>47725</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>29828</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>29828</TotalAssetsEOYFMVAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowSFAS117Ind>X</OrgDoesNotFollowSFAS117Ind>
        <AdditionalPaidInCapitalBOYAmt>47725</AdditionalPaidInCapitalBOYAmt>
        <AdditionalPaidInCapitalEOYAmt>29828</AdditionalPaidInCapitalEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>47725</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>29828</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>47725</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>29828</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>47725</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>-17897</ExcessRevenueOverExpensesAmt>
        <SubtotalAmt>29828</SubtotalAmt>
        <TotNetAstOrFundBalancesEOYAmt>29828</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <QlfyUndSect4940eReducedTaxGrp>
        <LiableSection4942TaxInd>false</LiableSection4942TaxInd>
        <AdjustedQlfyDistriYr1Amt>5876346</AdjustedQlfyDistriYr1Amt>
        <NetVlNoncharitableAssetsYr1Amt>200449</NetVlNoncharitableAssetsYr1Amt>
        <DistributionYr1Rt>29.31592</DistributionYr1Rt>
        <AdjustedQlfyDistriYr2Amt>5323363</AdjustedQlfyDistriYr2Amt>
        <NetVlNoncharitableAssetsYr2Amt>114617</NetVlNoncharitableAssetsYr2Amt>
        <DistributionYr2Rt>46.44479</DistributionYr2Rt>
        <AdjustedQlfyDistriYr3Amt>4932334</AdjustedQlfyDistriYr3Amt>
        <NetVlNoncharitableAssetsYr3Amt>44333</NetVlNoncharitableAssetsYr3Amt>
        <DistributionYr3Rt>111.25649</DistributionYr3Rt>
        <AdjustedQlfyDistriYr4Amt>6634787</AdjustedQlfyDistriYr4Amt>
        <NetVlNoncharitableAssetsYr4Amt>18285</NetVlNoncharitableAssetsYr4Amt>
        <DistributionYr4Rt>362.85409</DistributionYr4Rt>
        <AdjustedQlfyDistriYr5Amt>4142272</AdjustedQlfyDistriYr5Amt>
        <NetVlNoncharitableAssetsYr5Amt>81223</NetVlNoncharitableAssetsYr5Amt>
        <DistributionYr5Rt>50.99876</DistributionYr5Rt>
        <TotalDistributionRt>600.87005</TotalDistributionRt>
        <AverageDistributionRt>120.17401</AverageDistributionRt>
        <NetVlNoncharitableAssetsAmt>125821</NetVlNoncharitableAssetsAmt>
        <AdjNetVlNoncharitableAssetsAmt>15120414</AdjNetVlNoncharitableAssetsAmt>
        <AdjNonchrtblNetInvstIncmPctAmt>15120414</AdjNonchrtblNetInvstIncmPctAmt>
        <QualifyingDistributionsAmt>5144381</QualifyingDistributionsAmt>
      </QlfyUndSect4940eReducedTaxGrp>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>0</InvestmentIncomeExciseTaxAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>false</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>false</MoreThan100SpentInd>
        <Form1120POLFiledInd>false</Form1120POLFiledInd>
        <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>false</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
        <Form990TFiledInd>false</Form990TFiledInd>
        <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>true</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>true</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>CA</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>true</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>false</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>false</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>false</OwnControlledEntityInd>
        <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>true</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>WWW.GUTHYJACKSONFOUNDATION.ORG</WebsiteAddressTxt>
        <PersonsWithBooksName>
          <BusinessNameLine1Txt>LaRue Corrigan McCormick &amp; T</BusinessNameLine1Txt>
        </PersonsWithBooksName>
        <PhoneNum>8185879303</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>5959 Topanga Canyon Blvd Suite 180</AddressLine1Txt>
          <CityNm>Woodland Hills</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91367</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>false</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>false</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>false</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>false</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>false</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>false</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>false</PaymentToGovernmentOfficialInd>
        <ActsFailToQlfyAsExceptionsInd>false</ActsFailToQlfyAsExceptionsInd>
        <UncorrectedPriorActsInd>false</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>false</UndistributedIncomePYInd>
        <UndistrIncmSect4942a2NotAppInd>false</UndistrIncmSect4942a2NotAppInd>
        <BusinessHoldingsInd>false</BusinessHoldingsInd>
        <ExcessBusinessHoldingsInd>false</ExcessBusinessHoldingsInd>
        <JeopardyInvestmentsInd>false</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>false</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>false</InfluenceLegislationInd>
        <InfluenceElectionInd>false</InfluenceElectionInd>
        <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>false</NoncharitablePurposeInd>
        <TransactionsFailToQlfyAsExcInd>false</TransactionsFailToQlfyAsExcInd>
        <MaintainedExpenditureRspnsInd>false</MaintainedExpenditureRspnsInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
        <ProceedsOrNetIncomeInd>false</ProceedsOrNetIncomeInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>William R Guthy</PersonNm>
          <USAddress>
            <AddressLine1Txt>3340 Ocean Park Blvd Suite 30</AddressLine1Txt>
            <CityNm>Santa Monica</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90405</ZIPCd>
          </USAddress>
          <TitleTxt>CO TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>20.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Victoria Jackson</PersonNm>
          <USAddress>
            <AddressLine1Txt>3340 Ocean Park Blvd Suite 30</AddressLine1Txt>
            <CityNm>Santa Monica</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90405</ZIPCd>
          </USAddress>
          <TitleTxt>CO TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>20.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName referenceDocumentId="ContractorProfExpln">
            <BusinessNameLine1Txt>CYTOSOLVE INC</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>701 CONCORD AVENUE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02138</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>MEDICAL RESEARCH</ServiceTypeTxt>
          <CompensationAmt>100000</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
      </OfficerDirTrstKeyEmplInfoGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>0</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>127737</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>0</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>127737</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>127737</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>1916</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>125821</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>6291</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>6291</MinimumInvestmentReturnAmt>
        <DistributableBeforeAdjAmt>6291</DistributableBeforeAdjAmt>
        <DistributableBeforeDedAmt>6291</DistributableBeforeDedAmt>
        <DistributableAsAdjustedAmt>6291</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <QualifyingDistriPartXIIGrp>
        <ExpensesAndContributionsAmt>5144381</ExpensesAndContributionsAmt>
        <QualifyingDistributionsAmt>5144381</QualifyingDistributionsAmt>
        <AdjustedQualifyingDistriAmt>5144381</AdjustedQualifyingDistriAmt>
      </QualifyingDistriPartXIIGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>6291</DistributableAsAdjustedAmt>
        <ExcessDistributionCyovYr5Amt>4138211</ExcessDistributionCyovYr5Amt>
        <ExcessDistributionCyovYr4Amt>6633873</ExcessDistributionCyovYr4Amt>
        <ExcessDistributionCyovYr3Amt>4930117</ExcessDistributionCyovYr3Amt>
        <ExcessDistributionCyovYr2Amt>5317632</ExcessDistributionCyovYr2Amt>
        <ExcessDistributionCyovYr1Amt>5866324</ExcessDistributionCyovYr1Amt>
        <TotalExcessDistributionCyovAmt>26886157</TotalExcessDistributionCyovAmt>
        <QualifyingDistributionsAmt>5144381</QualifyingDistributionsAmt>
        <TreatedAsDistriFromCorpusAmt>0</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>6291</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>5138090</RemainingDistriFromCorpusAmt>
        <TotalCorpusAmt>32024247</TotalCorpusAmt>
        <UndistributedIncomeCYAmt>0</UndistributedIncomeCYAmt>
        <ExcessDistriCyovFromYr5Amt>4138211</ExcessDistriCyovFromYr5Amt>
        <ExcessDistriCyovToNextYrAmt>27886036</ExcessDistriCyovToNextYrAmt>
        <ExcessFromYear4Amt>6633873</ExcessFromYear4Amt>
        <ExcessFromYear3Amt>4930117</ExcessFromYear3Amt>
        <ExcessFromYear2Amt>5317632</ExcessFromYear2Amt>
        <ExcessFromYear1Amt>5866324</ExcessFromYear1Amt>
        <ExcessFromCurrentYearAmt>5138090</ExcessFromCurrentYearAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <ContributingManagerNm>William R Guthy</ContributingManagerNm>
        <ContributingManagerNm>Victoria Jackson</ContributingManagerNm>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>ALL GREATER GOOD FOUNDATION</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>8910 UNIVERSITY CENTER LANE</AddressLine1Txt>
            <CityNm>SAN DIEGO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92122</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>none</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>POF</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NMO MEDICAL RESEARCH MANAGEMENT &amp; SUPERVISION</GrantOrContributionPurposeTxt>
          <Amt>2340000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>STANFORD UNIVERSITY SCHOOL OF MEDIC</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3440 WALNUT AVENUE</AddressLine1Txt>
            <CityNm>FREMONT</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94538</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>none</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>study blood biomarkers to predict desease activity in NMO</GrantOrContributionPurposeTxt>
          <Amt>55000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIV OF CALIFORNIA SAN FRANCISCO</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 CALIFORNIA STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94118</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>none</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>second generation rat models of NMO</GrantOrContributionPurposeTxt>
          <Amt>25850</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIV OF CALIFORNIA SAN FRANCISCO</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>220 MONTGOMERY STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>none</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NMO blocker therapy studies</GrantOrContributionPurposeTxt>
          <Amt>82500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>MAYO CLINIC</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>clinical program management in NMO neurology</GrantOrContributionPurposeTxt>
          <Amt>84800</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>JOHN HOPKINS UNIVERSITY</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>600 N WOLFE STREET</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21287</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Study the effect of anti-VEGF therapy for NMO</GrantOrContributionPurposeTxt>
          <Amt>82202</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIVERSITY OF COLORADO - DENVER</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1250 14TH STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80217</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>determination of the role of hypercomplement-activating aqp4-igc in NMO</GrantOrContributionPurposeTxt>
          <Amt>223029</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>MASSACHUSETTS GENERAL HOSPITAL</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02114</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>research clinical and mri features of nmo spectrum disorders in children</GrantOrContributionPurposeTxt>
          <Amt>27500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>ST GEORGE UNIVERSITY OF LONDON</RecipientPersonNm>
          <RecipientForeignAddress>
            <AddressLine1Txt>CRANMER TERRACE</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
            <ForeignPostalCd>SW17 0RE</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Pathogenesis of seropositive and seronegative nmo</GrantOrContributionPurposeTxt>
          <Amt>49500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>CLEVELAND CLINIC</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>research effects of nmo-igg at the blood barrier</GrantOrContributionPurposeTxt>
          <Amt>60236</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>ICAHN SCHOOL OF MEDICINE</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1428 MADISON AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Open-label add-on trial of cetirizine for nmo</GrantOrContributionPurposeTxt>
          <Amt>68750</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>MT SINAI HOSPITAL</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE GUSTAVE L LEVY PLACE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>research ANTI-VEGF THERAPY FOR NMO</GrantOrContributionPurposeTxt>
          <Amt>52710</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>NY UNIV SCHOOL OF MEDICINE</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>550 1ST AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH CELEBRAL ULTRA HIGH FIELD MR imaging in nmo</GrantOrContributionPurposeTxt>
          <Amt>39960</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIVERSITY OF OXFORD</RecipientPersonNm>
          <RecipientForeignAddress>
            <AddressLine1Txt>WELLINGTON SQUARE</AddressLine1Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
            <ForeignPostalCd>OX1 2JD</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH MAGNETIC RESONANCE SPECTROSCOPY and high field spinal cord mri for studying nmo</GrantOrContributionPurposeTxt>
          <Amt>50123</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>STANFORD UNIVERSITY SCHOOL OF MEDIC</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3440 WALNUT AVENUE</AddressLine1Txt>
            <CityNm>FREEMONT</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94538</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>collaborative intl research in clinical and longitudinal experience in nmo studies</GrantOrContributionPurposeTxt>
          <Amt>55000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIVERSITY OF UTAH</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>201 PRESIDENT CIRCLE 201</AddressLine1Txt>
            <CityNm>SALT LAKE CITY</CityNm>
            <StateAbbreviationCd>UT</StateAbbreviationCd>
            <ZIPCd>84112</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESTABLISH FUNCTIONAL INFRASTRUCTURE FOR AN NMO PATIENT REGISTRY</GrantOrContributionPurposeTxt>
          <Amt>697293</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIV OF CALIFORNIA SAN FRANCISCO</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 CALIFORNIA STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94118</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH AQP-4 SPECIFIC IMMUNOTHERAPY in nmo</GrantOrContributionPurposeTxt>
          <Amt>316344</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>ST GEORGE'S UNIVERSITY OF LONDON</RecipientPersonNm>
          <RecipientForeignAddress>
            <AddressLine1Txt>CRANMER TERRACE</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
            <ForeignPostalCd>SW17 0RE</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH to determine the role of complement regulators in nmo and pathogenecity of autoantibodies in AQP4-igg</GrantOrContributionPurposeTxt>
          <Amt>53327</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIV OF CALIFORNIA SAN FRANCISCO</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 CALIFORNIA STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94118</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERATION, CHARACTERIZATION AND APPLICATION OF AQP4 KNOCKOUT RAT</GrantOrContributionPurposeTxt>
          <Amt>236337</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIVERSITY OF BRITISH COLUMBIA</RecipientPersonNm>
          <RecipientForeignAddress>
            <AddressLine1Txt>3333 UNIVERSITY WAY</AddressLine1Txt>
            <CityNm>KELOWNA</CityNm>
            <ProvinceOrStateNm>BRITISH COLUMBIA</ProvinceOrStateNm>
            <CountryCd>CA</CountryCd>
            <ForeignPostalCd>V1V 1V7</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COLLABORATIVE INTL REEARCH STUDIES IN NMO LONGITUDINAL CLINICAL STUDIES</GrantOrContributionPurposeTxt>
          <Amt>40016</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIVERSITY OF COLORADO - DENVER</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1250 14TH STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80217</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NMO SPECTRUM DISORDERS LONGITUDINAL CLINICAL STUDY RESEARCH SITE</GrantOrContributionPurposeTxt>
          <Amt>40065</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>DUKE UNIVERSITY</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>2138 CAMPUS DRIVE</AddressLine1Txt>
            <CityNm>DURHAM</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27708</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH IN IDENTIFYING MICROBIAL SELF ANTIGENOMES OF NMO/NMOSD</GrantOrContributionPurposeTxt>
          <Amt>164490</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>STANFORD UNIVERSITY</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>450 SERRA MALL</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NMO LONGITUDINAL CLINICAL STUDY RESEARCH SITE</GrantOrContributionPurposeTxt>
          <Amt>66000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>UNIVERSITY OF COLORADO</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1250 14TH STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80217</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PRODUCTION OF AQP-4 SPECIFIC MONOCLONAL CSR RABS ANTIBODIES</GrantOrContributionPurposeTxt>
          <Amt>75815</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>4986847</TotalGrantOrContriPdDurYrAmt>
      </SupplementaryInformationGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>false</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>false</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>false</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>false</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>false</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>false</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>false</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>false</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>false</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>false</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="14000265" softwareVersionNum="2014v5.0">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorPersonNm>WILLIAM R GUTHY</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>3340 OCEAN PARK BLVD 3055</AddressLine1Txt>
          <CityNm>SANTA MONICA</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90405</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>4987000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>2</ContributorNum>
        <ContributorPersonNm>NANCY REIMER</ContributorPersonNm>
        <ContributorForeignAddress>
          <AddressLine1Txt>2557 HARRIER DR</AddressLine1Txt>
          <CityNm>COQUITLAM</CityNm>
          <ProvinceOrStateNm>BRITISH COLUMBIA</ProvinceOrStateNm>
          <CountryCd>CA</CountryCd>
          <ForeignPostalCd>V3E 2A5</ForeignPostalCd>
        </ContributorForeignAddress>
        <TotalContributionsAmt>8500</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>3</ContributorNum>
        <ContributorPersonNm>MEDIMMUNE LLC</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>HEADQUARTERS ONE MEDIMMUNE WY</AddressLine1Txt>
          <CityNm>GAITHERSBURG</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20878</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>25000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>4</ContributorNum>
        <ContributorPersonNm>ALAN ALICE ZAFF</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>17 WHITMANS BROOK DR</AddressLine1Txt>
          <CityNm>NORTH EASTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02356</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>10000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>5</ContributorNum>
        <ContributorPersonNm>SETH KLARMAN</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>1018 PAMELA DR</AddressLine1Txt>
          <CityNm>BEVERY HILLS</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90210</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>10000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <AccountingFeesSchedule documentId="AccountingFeesSchedule" softwareId="14000265" softwareVersionNum="2014v5.0">
      <AccountingFeesDetail>
        <CategoryTxt>HARVEY A LAWSON CPA</CategoryTxt>
        <Amt>4950</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>4950</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <ContractorCompensationExpln documentId="ContractorProfExpln" softwareId="14000265" softwareVersionNum="2014v5.0">
      <ContractorCompExplnGrp>
        <ContractorBusinessName>
          <BusinessNameLine1Txt>CYTOSOLVE INC</BusinessNameLine1Txt>
        </ContractorBusinessName>
        <ExplanationTxt>MEDICAL RESEARCH COLLABORATIVE</ExplanationTxt>
      </ContractorCompExplnGrp>
    </ContractorCompensationExpln>
    <LegalFeesSchedule documentId="LegalFeesSchedule" softwareId="14000265" softwareVersionNum="2014v5.0">
      <LegalFeesGrp>
        <CategoryTxt>JEFFER MANGELS BUTLER &amp; MARMARO LLP</CategoryTxt>
        <LegalFeesAmt>26907</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>26907</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherExpensesSchedule documentId="OtherExpensesSchedule" softwareId="14000265" softwareVersionNum="2014v5.0">
      <OtherExpensesScheduleGrp>
        <Desc>BANK FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>101</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>101</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>INSURANCE</Desc>
        <RevenueAndExpensesPerBooksAmt>4627</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>4627</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>LAB TESTING</Desc>
        <RevenueAndExpensesPerBooksAmt>13978</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>13978</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>OFFICE EXPENSE</Desc>
        <RevenueAndExpensesPerBooksAmt>295</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>295</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>POSTAGE &amp; SHIPPING</Desc>
        <RevenueAndExpensesPerBooksAmt>1355</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>1355</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>SECRETARY OF STATE</Desc>
        <RevenueAndExpensesPerBooksAmt>21</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>21</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherProfessionalFeesSchedule documentId="OtherProfessionalFeesSchedule" softwareId="14000265" softwareVersionNum="2014v5.0">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>AY PAPI PRODUCTIONS, INC</CategoryTxt>
        <Amt>5300</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>5300</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>CYTOSOLVE TECHNOLOGY PLATFORM</CategoryTxt>
        <Amt>100000</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>100000</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="TaxesSchedule" softwareId="14000265" softwareVersionNum="2014v5.0">
      <TaxesDetail>
        <CategoryTxt>FRANCHISE TAX BOARD</CategoryTxt>
        <Amt>10</Amt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>REGISTRY OF CHARITABLE TRUST</CategoryTxt>
        <Amt>150</Amt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>